Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Godavari Biorefineries Limited is active in the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 1 pending office action. This action is being handled by 1 distinct examiner in 1 distinct art unit, reflecting a concentrated effort in a specific technical field. This concentration indicates that the company's intellectual property is being evaluated within a single specialized group at the USPTO.
The busiest examiner for the portfolio is SHIAO, YIH-HORNG. This examiner is managing 1 busiest examiner pending action, which is the only pending action for the company. The alignment between the busiest examiner's workload and the 1 pending office action highlights a focused prosecution phase with no current diversification across different examiners. For practitioners, this means the examiner's interpretation of the prior art will be the factor in the success of the current prosecution efforts within the distinct art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIAO, YIH-HORNG | 1 | 72.6% | +75.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18692298 | PHARMACEUTICAL COMPOSITION AND A PROCESS TO PREPARE THE SAME | SHIAO, YIH-HORNG | — |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18692298 | PHARMACEUTICAL COMPOSITION AND A PROCESS TO PREPARE THE SAME | SHIAO, YIH-HORNG | 1691 | §102§103§112DP | Non-Final OA | — | Pending | Mar 14, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGodavari Biorefineries Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Yih-Horng Shiao has the most, with 1 of Godavari Biorefineries Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
